fig1

Exploring new therapeutics for Duchenne muscular dystrophy and related cardiomyopathy

Figure 1. Therapeutic approaches for DMD. General therapeutic designs currently available or under investigation for DMD, which can be broadly classified into pharmacological, cell and cell - derived biologics, and gene therapies. DMD: Duchenne muscular dystrophy.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/